<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Neurol</journal-id><journal-id journal-id-type="iso-abbrev">Front Neurol</journal-id><journal-id journal-id-type="publisher-id">Front. Neurol.</journal-id><journal-title-group><journal-title>Frontiers in Neurology</journal-title></journal-title-group><issn pub-type="epub">1664-2295</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6928139</article-id><article-id pub-id-type="doi">10.3389/fneur.2019.01324</article-id><article-categories><subj-group subj-group-type="heading"><subject>Neurology</subject><subj-group><subject>Original Research</subject></subj-group></subj-group></article-categories><title-group><article-title>The Blood Levels of Trace Elements Are Lower in Children With Tic Disorder: Results From a Retrospective Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Qian</surname><given-names>Ruiying</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/792488/overview"/></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>You</surname><given-names>Liuqing</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/864811/overview"/></contrib><contrib contrib-type="author"><name><surname>Zhao</surname><given-names>Yanmin</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/864989/overview"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Shuxian</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/809618/overview"/></contrib><contrib contrib-type="author"><name><surname>Shen</surname><given-names>Jue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/782274/overview"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Lihua</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/782239/overview"/></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Cuiwei</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/809646/overview"/></contrib><contrib contrib-type="author"><name><surname>Jiang</surname><given-names>Peifang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/776672/overview"/></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Zhefeng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/797107/overview"/></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/756233/overview"/></contrib><contrib contrib-type="author"><name><surname>Mao</surname><given-names>Shanshan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="c001"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="http://loop.frontiersin.org/people/782494/overview"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Department of Neurology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff><aff id="aff2"><sup>2</sup><institution>Department of Epidemiology and Biostatistics, Zhejiang University School of Public Health</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff><aff id="aff3"><sup>3</sup><institution>Department of General Practice, Community Health Service Center</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff><aff id="aff4"><sup>4</sup><institution>Department of Pulmonology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health</institution>, <addr-line>Hangzhou</addr-line>, <country>China</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Alberto Spalice, Policlinico Umberto I, Italy</p></fn><fn fn-type="edited-by"><p>Reviewed by: Mariangela Gulisano, University of Catania, Italy; Michele Roccella, University of Palermo, Italy</p></fn><corresp id="c001">*Correspondence: Shanshan Mao <email>6307003@zju.edu.cn</email></corresp><fn fn-type="other" id="fn001"><p>This article was submitted to Pediatric Neurology, a section of the journal Frontiers in Neurology</p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>12</month><year>2019</year></pub-date><pub-date pub-type="collection"><year>2019</year></pub-date><volume>10</volume><elocation-id>1324</elocation-id><history><date date-type="received"><day>15</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>29</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2019 Qian, Ma, You, Zhao, Li, Shen, Jiang, Yang, Jiang, Yuan, Gao and Mao.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Qian, Ma, You, Zhao, Li, Shen, Jiang, Yang, Jiang, Yuan, Gao and Mao</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p><bold>Background:</bold> Tic disorders (TD) are common neuropsychiatric disorders among children and adolescents. It is controversial that trace elements may participate in the pathogenesis of TD. Our study aimed to investigate the trace elements status of zinc (Zn), copper (Cu), iron (Fe), and magnesium (Mg) in children with TD, in comparison to healthy controls.</p><p><bold>Methods:</bold> The medical records of eligible TD children and normal healthy children from January 1 to December 31, 2018 in the outpatient clinic were retrospectively reviewed. The clinical information of all subjects were collected including age, gender, diagnosis, previous health records, and serum trace elements level (Cu, Zn, Fe, Mg) at the time of diagnosis before initiating treatment.</p><p><bold>Results:</bold> In total, 1204 TD children (7.63 &#x000b1; 2.45 years) and 1,220 healthy children (7.27 &#x000b1; 3.15 years) who were divided into two gender and three age groups (2&#x02013;4years, 5&#x02013;9years, &#x02265;10 years) were reviewed in our study. Our study showed that TD children generally had lower whole blood levels of Zn, Cu, Fe than the normal controls (<italic>P</italic> &#x0003c; 0.01). No significant difference was observed in whole blood levels of Mg. After adjusting for gender, the trends still remained. Further analysis was performed according to age, the trends still remained in Zn and Fe in all age groups (<italic>P</italic> &#x0003c; 0.05). However, we observed an almost significantly (<italic>P</italic> = 0.055) lower level of Cu in TD of 2&#x02013;4 years group while significant differences in other two groups (<italic>P</italic> &#x0003c; 0.01). Further multiple linear regression and point biserial correlation showed that the lower blood levels of Zn, Cu, and Fe were correlated with the incidence of TD.</p><p><bold>Conclusion:</bold> The present results indicated that lower blood levels of zinc, iron, copper were associated with TD. Trace elements may be used as an auxiliary treatment for TD and need to be further explored.</p></abstract><kwd-group><kwd>tic disorders (TD)</kwd><kwd>trace elements</kwd><kwd>zinc (Zn)</kwd><kwd>copper (Cu)</kwd><kwd>iron (Fe)</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content></funding-source><award-id rid="cn001">81741076</award-id><award-id rid="cn001">81801490</award-id></award-group></funding-group><counts><fig-count count="0"/><table-count count="5"/><equation-count count="0"/><ref-count count="52"/><page-count count="8"/><word-count count="6265"/></counts></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Tic disorders (TD), including transient tic disorder (TTD), chronic motor or vocal tic disorder (CTD), and Tourette syndrome (TS), are common neuropsychiatric disorders that often occur in children and adolescents. They are characterized by sudden, rapid, unconscious motor movements or uttered sounds that involve discrete muscle groups. Transient tics occur in up to 25% of healthy children. The prevalence of chronic tic disorder is about 1&#x02013;3% and that for TS varies from 0.1 to 1%, with a male: female ratio of approximately 4:1 (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). The age of tic onset is mainly in early kindergarten and school years with a range from 3 to 11 years and its severity usually peaks at 12 years old. Most patients show an ability to suppress tics for short periods but report an increase of symptoms shortly after. About 5&#x02013;10% patients exhibit a persistent impairing system or functioning that lasts into adulthood, resulting in a permanent impairment of social and academic function which could affect one's lifetime achievement (<xref rid="B3" ref-type="bibr">3</xref>).</p><p>TD is currently recognized as a polygenic genetic disorder and is affected by a variety of environmental factors (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>). An inherited nature for TD supported by findings, including a population-based heritability estimate of 0.77 (a value of 1 indicating 100% heritability), a 15-fold increased risk of developing Tourette syndrome/chronic motor or vocal tic disorder in siblings of individuals with Tourette syndrome, a positive family history for tics in about one-half of patients, and monozygotic twins having an 86% concordance rate with chronic motor or vocal tic disorder compared to 20% in dizygotic twins (<xref rid="B6" ref-type="bibr">6</xref>). Although hundreds of genes appear to be involved, only a small proportion of risk has been explained. A huge study of shared data from over a million people with various neurologic and psychiatric disorders revealed that TS shares common variant genetic risk with obsessive compulsive disorder (OCD), major depression, and migraine, especially migraine with aura (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). There is much literature exploring immune dysregulation in TS, including microglial dysfunction, reduced numbers of regulatory T cells, altered gamma globulin, and an increased response to pathogens, and these have been proposed as potential contributing etiologic factors for tics (<xref rid="B9" ref-type="bibr">9</xref>). In some cases, behavioral changes and tics occur after streptococcal infection and are currently thought to be associated with autoimmune responses following streptococcal infection. There is some evidence that these patients can respond to antibiotics or immune therapy, which is still controversial (<xref rid="B10" ref-type="bibr">10</xref>). Other researches on pathogenesis involve prenatal/perinatal infections, psychosocial situation and environmental factors (<xref rid="B9" ref-type="bibr">9</xref>). However, the mechanism of TD pathogenies has not been found yet. Therefore, the treatment of TD could be more complex and diversified as well.</p><p>In current clinics, treatment of tic disorder mainly depends on medicines (<xref rid="B11" ref-type="bibr">11</xref>). The conventional medicines increase the activity of dopamine and norepinephrine and those stimulants have a high effectiveness in TD treatment. However, it also has noticeable side effects, such as: loss of appetite and weight, growth inhibition, abdominal pain, headaches, sleeping problems, increased blood pressure, and even addiction. Therefore, scientists and parents keep seeking for alternative tools of controlling TD. Trace elements such as copper (Cu), zinc (Zn), iron (Fe), and magnesium (Mg) which are currently known to be essential for brain development and physiology, including neurotransmitter synthesis (<xref rid="B12" ref-type="bibr">12</xref>), concentrations in the basal ganglia (<xref rid="B13" ref-type="bibr">13</xref>), neurotransmitters and dopamine metabolism (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). They are proposed to be one of possible key factors of TD pathology (<xref rid="B7" ref-type="bibr">7</xref>), and received more and considerable attention from the scientific community. TD coexists with many common comorbidities, the most common of which is attention deficit hyperactivity disorder (ADHD). Some studies have found that serum Zn and Fe levels are lower in children with ADHD than those in normal children, but this phenomenon has not been observed in Mg or Cu (<xref rid="B16" ref-type="bibr">16</xref>). Moreover, the results from existing literatures are not always consistent and the parameters of the state of trace elements are also controversial (<xref rid="B17" ref-type="bibr">17</xref>). Our study analyzed the relationship between trace elements and TD in children based on a large sample size. We expect that the study may inspire the development of new approaches to treat TD.</p></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec><title>Study Design</title><p>In this study we measured the levels of trace elements in children with TD and healthy children aged 2&#x02013;15 years in order to assess whether the levels of trace elements in children with TD are different.</p></sec><sec><title>Study Procedure</title><p>Our study retrospectively reviewed the electronic medical record database of pediatric patients newly diagnosed with TD through comprehensive evaluation and control subjects at the Children's Hospital of Zhejiang University School of Medicine between January 1, 2018 and December 31, 2018.</p><p>The children included in the TD group should meet the following criteria: (1) diagnosed as TD through a comprehensive assessment according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5): one or more motor tics or vocal tics occurring several times daily; (2) between the ages of 2 and 15 years old; (3) without history of TD treatment; (4) excluding similar symptoms caused by other physical diseases and substance use. Individuals were excluded if they had (1) a neuroimaging diagnosis with brain structural abnormalities; (2) history of taking dopamine receptor blockers, cocaine and other drugs for controlling TD; (3) combined with other diseases such as cardiovascular diseases, severe malnutrition, severe digestive system diseases such as severe gastrointestinal stenosis and dysphagia. The control group was recruited from children who underwent health checkups within the same time period. TD and other serious medical diseases were excluded by detailed examination.</p><p>Clinical information of all subjects were collected including age, gender, diagnosis, family history of TD, previous health record, and serum trace element level at the time of diagnosis before initiating treatment.</p><p>A total of 1,204 children were enrolled in TD group and 1,220 children were enrolled in control group. The characteristics of the subjects are shown in <xref rid="T1" ref-type="table">Table 1</xref>. The mean age of the controls and children with TD was 7.27 &#x000b1; 3.15 and 7.63 &#x000b1; 2.45 years old, respectively. For further analysis, the children were divided either based on gender into two groups (1,669 males and 755 females) or based on age into three groups (2&#x02013;4 years, <italic>n</italic> = 490; 5&#x02013;9 years, <italic>n</italic> = 1,457; &#x02265;10 years, <italic>n</italic> = 477).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Basic characteristics of children in the TD group and normal control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Control group <italic>N</italic> (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TD group</bold><break/>
<bold><italic>N</italic> (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1">Age, years</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Mean &#x000b1; <italic>SD</italic></td><td valign="top" align="center" rowspan="1" colspan="1">7.27 &#x000b1; 3.15</td><td valign="top" align="center" rowspan="1" colspan="1">7.63 &#x000b1; 2.45</td><td valign="top" align="center" rowspan="1" colspan="1">0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;2~</td><td valign="top" align="center" rowspan="1" colspan="1">325 (26.64%)</td><td valign="top" align="center" rowspan="1" colspan="1">165 (13.70%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;5~</td><td valign="top" align="center" rowspan="1" colspan="1">636 (52.13%)</td><td valign="top" align="center" rowspan="1" colspan="1">821 (68.19%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;10~</td><td valign="top" align="center" rowspan="1" colspan="1">259 (21.23%)</td><td valign="top" align="center" rowspan="1" colspan="1">218 (18.11%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" colspan="3" rowspan="1">Sex</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Male</td><td valign="top" align="center" rowspan="1" colspan="1">732 (60.00%)</td><td valign="top" align="center" rowspan="1" colspan="1">937 (77.82%)</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Female</td><td valign="top" align="center" rowspan="1" colspan="1">488 (40.00%)</td><td valign="top" align="center" rowspan="1" colspan="1">267 (22.18%)</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec><title>Trace Element Detection</title><p>Trace metal analysis were performed with a multichannel atomic absorption spectrophotometer-MB5 (AAS; Beijing Purkinje General Instrument Co., Ltd., Beijing, China). The detection thresholds of these instruments for Zn, Cu, Fe, and Mg are 0.01 &#x003bc;mol/l, 0.01 &#x003bc;mol/l, 0.01 mmol/l, and 0.01 mmol/l, respectively.</p></sec><sec><title>Data Analysis</title><p>Statistical analysis was performed using SPSS (version 20.0) statistical software. The data were expressed as mean &#x000b1; standard deviation. The comparison between two groups was performed by independent sample <italic>t</italic>-test. The comparison between multiple groups was analyzed by one-way ANOVA. The comparison between groups was performed by SHK-q test. The counting data were presented as percentage (%). The chi-square test was used to compare the demographic data of two groups. Multiple linear regression and point biserial correlation was used to analyze the relationship between TD status and serum trace elements. <italic>P</italic> &#x0003c; 0.05 was considered statistically significant.</p></sec><sec><title>Ethics Statement</title><p>The research protocol was approved by the institutional review committee of the Children's Hospital of Zhejiang University School of Medicine (2019-IRB-090). According to nature of the study, informed consent was waived by the Institutional Review Board.</p></sec></sec><sec sec-type="results" id="s3"><title>Results</title><p>Two thousand four hundred twenty-four children were included into this study. Of these, 1,669 (68.85%) children were males and the mean &#x000b1; SD age was (7.54 &#x000b1; 2.81) years. The basic characteristics of the samples are shown in <xref rid="T1" ref-type="table">Table 1</xref>. TD group was older than control group (7.63 vs. 7.27, <italic>P</italic> &#x0003c; 0.001) and had a higher proportion of males (77.82 vs. 60.00%, <italic>P</italic> &#x0003c; 0.001).</p><p>Differences between children in TD group and control group in terms of trace element level were presented in <xref rid="T2" ref-type="table">Table 2</xref>. TD group had a lower levels of Zn, Cu and Fe than the control group (78.90 vs. 83.90 &#x003bc;mol/l, 17.80 vs. 18.50 &#x003bc;mol/l, and 8.47 vs. 8.80 mmol/l, all <italic>P</italic> &#x0003c; 0.001). No statistical difference was observed regarding the level of Mg. After adjusting for gender and age, the trends still remained except &#x0201c;2&#x02013;4&#x0201d; age group. We observed a trend of lower level of Cu in TD of 2&#x02013;4 years group that is close to significance (<italic>P</italic> = 0.055), while it was significantly lower in the other two aging groups.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Trace element level of children in TD and control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Control group (Mean &#x000b1; <italic>SD</italic>)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TD group</bold><break/>
<bold>(Mean &#x000b1; <italic>SD</italic>)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="4" style="background-color:#bcbdc0" rowspan="1"><bold>TOTAL</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">83.90 &#x000b1; 12.10</td><td valign="top" align="center" rowspan="1" colspan="1">78.90 &#x000b1; 11.50</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">18.50 &#x000b1; 3.54</td><td valign="top" align="center" rowspan="1" colspan="1">17.80 &#x000b1; 3.28</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">8.80 &#x000b1; 0.94</td><td valign="top" align="center" rowspan="1" colspan="1">8.47 &#x000b1; 0.86</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">1.58 &#x000b1; 0.19</td><td valign="top" align="center" rowspan="1" colspan="1">0.318</td></tr><tr><td valign="top" align="left" colspan="4" style="background-color:#bcbdc0" rowspan="1"><bold>SEX</bold></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Male</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">84.30 &#x000b1; 12.20</td><td valign="top" align="center" rowspan="1" colspan="1">78.70 &#x000b1; 11.40</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">18.60 &#x000b1; 3.54</td><td valign="top" align="center" rowspan="1" colspan="1">17.80 &#x000b1; 3.27</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">8.85 &#x000b1; 0.967</td><td valign="top" align="center" rowspan="1" colspan="1">8.49 &#x000b1; 0.83</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.175</td><td valign="top" align="center" rowspan="1" colspan="1">1.58 &#x000b1; 0.19</td><td valign="top" align="center" rowspan="1" colspan="1">0.357</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>Female</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">83.30 &#x000b1; 11.90</td><td valign="top" align="center" rowspan="1" colspan="1">80.00 &#x000b1; 11.70</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">18.40 &#x000b1; 3.54</td><td valign="top" align="center" rowspan="1" colspan="1">17.70 &#x000b1; 3.31</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">8.73 &#x000b1; 0.89</td><td valign="top" align="center" rowspan="1" colspan="1">8.40 &#x000b1; 0.95</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.17</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.19</td><td valign="top" align="center" rowspan="1" colspan="1">0.949</td></tr><tr><td valign="top" align="left" colspan="4" style="background-color:#bcbdc0" rowspan="1"><bold>AGE</bold></td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>2</bold><bold>~</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">77.10 &#x000b1; 10.3</td><td valign="top" align="center" rowspan="1" colspan="1">74.10 &#x000b1; 11.30</td><td valign="top" align="center" rowspan="1" colspan="1">0.005</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">19.20 &#x000b1; 3.57</td><td valign="top" align="center" rowspan="1" colspan="1">18.60 &#x000b1; 3.37</td><td valign="top" align="center" rowspan="1" colspan="1">0.055</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">8.42 &#x000b1; 0.77</td><td valign="top" align="center" rowspan="1" colspan="1">8.27 &#x000b1; 0.77</td><td valign="top" align="center" rowspan="1" colspan="1">0.039</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.56 &#x000b1; 0.16</td><td valign="top" align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.19</td><td valign="top" align="center" rowspan="1" colspan="1">0.028</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>5</bold><bold>~</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">84.70 &#x000b1; 11.4</td><td valign="top" align="center" rowspan="1" colspan="1">79.20 &#x000b1; 11.00</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">18.40 &#x000b1; 3.38</td><td valign="top" align="center" rowspan="1" colspan="1">17.80 &#x000b1; 3.28</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">8.84 &#x000b1; 0.94</td><td valign="top" align="center" rowspan="1" colspan="1">8.45 &#x000b1; 0.93</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.18</td><td valign="top" align="center" rowspan="1" colspan="1">1.57 &#x000b1; 0.18</td><td valign="top" align="center" rowspan="1" colspan="1">0.793</td></tr><tr><td valign="top" align="left" colspan="4" rowspan="1"><bold>10</bold><bold>~</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">90.50 &#x000b1; 11.70</td><td valign="top" align="center" rowspan="1" colspan="1">81.7 &#x000b1; 12.3</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu (&#x003bc;mol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">17.80 &#x000b1; 3.70</td><td valign="top" align="center" rowspan="1" colspan="1">17.1 &#x000b1; 3.06</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">9.18 &#x000b1; 0.97</td><td valign="top" align="center" rowspan="1" colspan="1">8.71 &#x000b1; 0.95</td><td valign="top" align="center" rowspan="1" colspan="1">0.032</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg (mmol/l)</td><td valign="top" align="center" rowspan="1" colspan="1">1.58 &#x000b1; 0.18</td><td valign="top" align="center" rowspan="1" colspan="1">1.60 &#x000b1; 0.19</td><td valign="top" align="center" rowspan="1" colspan="1">0.306</td></tr></tbody></table></table-wrap><p>Point-biserial correlation of TD and the blood level of trace elements was shown in <xref rid="T3" ref-type="table">Table 3</xref>. The blood levels of Zn, Cu, and Fe were negatively associated with TD (<italic>r</italic> = &#x02212;0.205, &#x02212;0.181, and &#x02212;0.106, all <italic>P</italic> &#x0003c; 0.001).</p><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Point-biserial correlation of TD and the blood level of trace elements.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>r</italic></bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.205</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.181</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu</td><td valign="top" align="center" rowspan="1" colspan="1">&#x02212;0.106</td><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg</td><td valign="top" align="center" rowspan="1" colspan="1">0.02</td><td valign="top" align="center" rowspan="1" colspan="1">0.3175</td></tr></tbody></table></table-wrap><p>All element quantities were further transformed into categorical variables according to the clinical reference categories. The distributions of categorical trace element levels in two groups are given in <xref rid="T4" ref-type="table">Table 4</xref>. There existed significantly difference in categorical zinc distribution between two groups (<italic>P</italic> &#x0003c; 0.001). And the proportion of zinc deficiency in TD group was higher than that in control group (40.28 vs. 22.05%). No other statistical differences were observed in other categorical elements. The odds ratios (ORs) and 95% confidence intervals (95%CIs) for the relationship between zinc deficiency and the risk of TD are presented in <xref rid="T5" ref-type="table">Table 5</xref>. Zinc deficiency was independently and significantly associated with an increased risk of TD (OR = 2.52, 95%CI 2.09&#x02013;3.03), with adjustment for age and sex.</p><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>The relationship between the level of trace elements and TD.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"><bold>Elements</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Control group <italic>N</italic> (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>TD group</bold><break/>
<bold><italic>N</italic> (%)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold><italic>P</italic>-value</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Zn</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Low</td><td valign="top" align="center" rowspan="1" colspan="1">269 (22.05%)</td><td valign="top" align="center" rowspan="1" colspan="1">485 (40.28%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Normal</td><td valign="top" align="center" rowspan="1" colspan="1">951 (77.95%)</td><td valign="top" align="center" rowspan="1" colspan="1">719 (59.72%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Cu</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.4967</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Low</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0.08%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Normal</td><td valign="top" align="center" rowspan="1" colspan="1">1220 (100%)</td><td valign="top" align="center" rowspan="1" colspan="1">1203 (99.92%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fe</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.5646</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Low</td><td valign="top" align="center" rowspan="1" colspan="1">4 (0.33%)</td><td valign="top" align="center" rowspan="1" colspan="1">3 (0.25%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Normal</td><td valign="top" align="center" rowspan="1" colspan="1">1216 (99.67%)</td><td valign="top" align="center" rowspan="1" colspan="1">1200 (99.67%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;High</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">1 (0.08%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Mg</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.2466</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;Normal</td><td valign="top" align="center" rowspan="1" colspan="1">1220 (100%)</td><td valign="top" align="center" rowspan="1" colspan="1">1202 (99.83%)</td><td rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;High</td><td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td><td valign="top" align="center" rowspan="1" colspan="1">2 (0.17%)</td><td rowspan="1" colspan="1"/></tr></tbody></table></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Logistic regression analysis of zinc deficiency with TD.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1"><bold>Crude OR (95%CI)</bold></th><th valign="top" align="center" rowspan="1" colspan="1"><bold>Adjusted OR (95%CI)<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th></tr></thead><tbody><tr><td valign="top" align="left" colspan="3" rowspan="1"><bold>Zn</bold></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Low</td><td valign="top" align="center" rowspan="1" colspan="1">2.38 (2.00&#x02013;2.85)</td><td valign="top" align="center" rowspan="1" colspan="1">2.52 (2.09&#x02013;3.03)</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Normal</td><td valign="top" align="center" rowspan="1" colspan="1">1.00 (ref)</td><td valign="top" align="center" rowspan="1" colspan="1">1.00 (ref)</td></tr></tbody></table><table-wrap-foot><fn id="TN1"><label>a</label><p><italic>Adjusted for age and gender</italic>.</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p>Tic disorder is a neurodevelopmental disorder in children characterized by motor and vocal tics. The age of onset is mainly in early kindergarten and school years, ranging from 3 to 11 years (mean age is between 6 and 7 years). Tics can only be expressed as simple actions such as blinking, nose twitching, or complex movements such as jumping, uttering words, etc. Its severity usually peaks at around 12 years, with reducing frequency and severity at the end of adolescence (<xref rid="B18" ref-type="bibr">18</xref>). Epidemiological studies have shown that males account for the majority of TD patients (ratio 4:1) (<xref rid="B19" ref-type="bibr">19</xref>). About 5&#x02013;10% patients will exhibit persistent tics, which in turn leads to severe difficulties in social functioning (<xref rid="B20" ref-type="bibr">20</xref>). Emotional states such as excitement, depression, stress and anxiety are convinced to increase the severity of tics.</p><p>TD is currently recognized as a polygenic genetic disorder and is affected by a variety of environmental factors such as prenatal and perinatal noxious events, infections, and so on (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B21" ref-type="bibr">21</xref>). In the past few years, TD's genetic research has made great progress, however, more and more studies have shown that environmental factors contribute not only to the gene&#x02013;environment interaction but also at least to the disorders' severity and course.</p><p>Antipsychotics are the oldest and most effective treatment for tic disorder. Although most randomized controlled trials of antipsychotic treatment of tic disorder have shown superior efficacy over placebo, there are also many potentially serious adverse effects, including drug-induced dyskinesia, metabolism, and hormonal effects (<xref rid="B22" ref-type="bibr">22</xref>). In the past 15 years, patients with TD who have failed to respond to drugs and behavioral interventions can consider to try neuromodulation strategies primarily on, the deep brain stimulation (DBS) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B23" ref-type="bibr">23</xref>). The evidence of efficacy and safety of DBS in TS is based fundamentally on two larger studies targeting the globus pallidus pars interna (Gpi) and other four studies that used Gpi and thalamic intralaminar nuclei as targets and had smaller sample sizes (<xref rid="B24" ref-type="bibr">24</xref>&#x02013;<xref rid="B28" ref-type="bibr">28</xref>). However, due to recent differences in the results of randomized controlled trials for Gpi, there is still uncertainty in target selection. Another obstacle associated with DBS in TS is the relatively high frequency of post-operative infection complications, which may be associated with severe head twitching, self-manipulation of surgical wounds, or overreaction of immune inflammatory responses. In the future, there is an urgent need to develop more effective and safety treatments to control tics.</p><p>The patients' characteristics of children with TD in our cohort were consistent with those described in the literature (<xref rid="B1" ref-type="bibr">1</xref>). The mean age at diagnosis in our center was 7.63 years, with the highest proportion of children aged 5&#x02013;9 years, which is consistent with previous epidemiological studies (<xref rid="B1" ref-type="bibr">1</xref>). Male preponderance is also consistent with the general childhood population of TD (<xref rid="B29" ref-type="bibr">29</xref>).</p><p>Up to date, very few studies were devoted to exploring whether the level of trace elements changed in children with TD, there is still no consensus on this conclusion (<xref rid="B30" ref-type="bibr">30</xref>). Avrahami et al. (<xref rid="B17" ref-type="bibr">17</xref>) reported that serum ferritin levels are lower in children with TD compared with those without tics (TD). Ghosh and Burkman noted that the children with TD who had low serum ferritin levels (&#x02264;50 ng/mL) tended to have higher tic severity scores, but they did not obtain significant statistical differences (<xref rid="B31" ref-type="bibr">31</xref>), neither of above two studies involved other trace elements. Both two studies have small sample sizes and lack the normal healthy control groups. None of above found a relationship between serum iron (another important and sensitive parameter to estimate total body iron store) and tic disorder.TD coexists with many common comorbidities, including obsessive compulsive disorder (OCD) (26%), attention deficit hyperactive disorder (ADHD) (63%), anxiety (49%), depression (25%) (<xref rid="B32" ref-type="bibr">32</xref>), and sleep problems (60%) (<xref rid="B33" ref-type="bibr">33</xref>). Some studies had found that the level of trace elements in serum of children with ADHD is lower than that of control groups (<xref rid="B29" ref-type="bibr">29</xref>). Yang et al. (<xref rid="B16" ref-type="bibr">16</xref>) studied the most common four elements (Cu, Zn, Fe, Mg) routinely measured in clinical practice and reported that lower zinc levels were found in children with ADHD when compared with the normal control group while the other three elements didn't find such differences. Sun et al. (<xref rid="B34" ref-type="bibr">34</xref>) followed a systematic research for case-control studies on the serum zinc levels in Chinese children with ADHD published between 2000 and 2015 and obtained the similar conclusion as above.</p><p>In our study, the first advantage is that the designed subjects had a wide range of ages, we controlled inclusion and exclusion criteria to minimize the effects of other diseases, especially digestive diseases, on the intake of trace elements; second, we also measured four trace elements that are often collected in clinical practice; the third advantage is the large sample size, which can minimize the selective bias; fourthly, due to differences in age and gender distribution between the control and the TD group. In order to make the results credible, we've analyzed the two groups according to age and gender, respectively. These advantages make our results more powerful. In our study, we found that the average zinc level in the TD group was lower than that in the control group. The difference remained when adjusting the factor of gender and age, respectively. This conclusion is the same as previous researches (<xref rid="B16" ref-type="bibr">16</xref>). In addition, further point biserial correlation analysis of serum zinc and TD showed that the <italic>r</italic> value was negative, suggesting a negative correlation between serum zinc and TD. Interestingly, when we divided serum zinc into normal and deficiency according to the corresponding reference range, we found that a significant proportion of children with TD had zinc deficiency. Further correlation analysis showed that zinc deficiency was positively correlated with TD. The role of zinc in the pathophysiological process of TD is still unclear. Animal experiments and human studies suggest that there are several possible pathways that could be involved (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>): (1) zinc is an essential cofactor for over 300 enzymes (metalloenzymes and metalloenzyme complexes) required for the metabolism of carbohydrates, fatty acids, proteins, and nucleic acids. The metabolism of these nutrients is crucial for brain structure development and functional maintenance (<xref rid="B37" ref-type="bibr">37</xref>); (2) zinc is also essential for the production and regulation of the pineal hormone melatonin which helps to regulate dopamine function and is widely recognized as a key factor in the treatment of TD (<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>); (3) zinc can also bind to and regulate dopamine transporters, which are targets of psychostimulants for the treatment of ADHD (<xref rid="B40" ref-type="bibr">40</xref>). Based on these evidence, we believe that zinc supplementation may be an auxiliary treatment for TD children who with zinc deficiency. Some studies suggest that zinc as part of a mineral supplement may be a safe and effective intervention for ADHD (<xref rid="B41" ref-type="bibr">41</xref>). A large sample prospective cohort study is needed to confirm the efficacy and identify the real and efficient dose of zinc in TD.</p><p>Iron is another important trace element in the body and plays an important role in the development of the brain. Previous studies have found that iron deficiency affects children's cognitive, motor, and social functions. Changes in iron levels are associated with dopamine-related dyskinesias, such as restless legs syndrome (<xref rid="B42" ref-type="bibr">42</xref>). We selected serum iron which is relatively easy to obtain as a research object. Our study shows that serum iron levels in children with TD are lower than controls. After adjusting the factor of gender and age, respectively, the conclusion which is different from previous research results, is still remained (<xref rid="B33" ref-type="bibr">33</xref>). Further point biserial correlation analysis showed a negative correlation between serum iron and TD. The specific mechanism of TD and iron is not completely clear. Previous studies have found that iron is a major cofactor of the tyrosine hydroxylase enzyme which is a rate-limiting step in dopamine synthesis (<xref rid="B43" ref-type="bibr">43</xref>). Second, iron deficiency is associated with decreased density and activity of dopamine transporters, which in turn leads to an increase in extracellular dopamine and a decrease in dopamine receptors in the striatum (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). Third, iron deficiency may lead to basal ganglia dysfunction (<xref rid="B46" ref-type="bibr">46</xref>). Fourth, the imbalance of inhibitory/excitatory neurotransmitters is considered to be one of the main factors in the development of TD (<xref rid="B47" ref-type="bibr">47</xref>). Gamma-aminobutyric acid (GABA) is a major inhibitory neurotransmitter in the mammalian central nervous system and affects iron levels in the brain (<xref rid="B48" ref-type="bibr">48</xref>). Patients with TD have lower levels of GABA, which may result in a decrease in iron concentration in the basal ganglia (<xref rid="B48" ref-type="bibr">48</xref>). Fifth, imaging studies have shown that the level of thalamic iron in children with TD is reduced, which may be a potential cause of TD (<xref rid="B49" ref-type="bibr">49</xref>).</p><p>It is worth noting that only a small number of patients in our study have serum iron deficiency, while serum iron in most children with TD is within the normal reference range. Serum iron levels may not be consistent with iron levels in the brain. Therefore, serum iron may not be the optimal indicator for determining iron storage in children with TD in clinical work and need to be determined. Ghosh and Burkman noted that the iron sufficient patients receiving iron supplementations also showed improvement in their tic severity with time, while the tics in those without supplementation remained unchanged (<xref rid="B33" ref-type="bibr">33</xref>). It is suggested that iron sufficient patients may have relative iron deficiency in the brain. Therefore, for patients with normal but low serum iron levels, that whether regular iron supplementation is needed deserves to be further exploration.</p><p>Copper is essential for many enzymes, which play important roles in neurophysiology, including cellular antioxidants, dopamine metabolism, norepinephrine, catecholamine degradation (<xref rid="B50" ref-type="bibr">50</xref>). Excess copper levels and copper-mediated neurotoxicity may be associated with the formation of a copper-dopamine complex which oxidizes dopamine and might be related to depression and other mental problems such as schizophrenia, learning disabilities, hyperactivity, and so on (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>). At present, there are few studies to pay attention to the relationship between copper and tic disorder. Our study showed that serum copper levels in the TD group were lower than that in the control group which is different from previous studies (<xref rid="B16" ref-type="bibr">16</xref>). Further analysis based on age, the other two groups obtained similar results as above, whereas for the 2&#x02013;4 age group, there was no difference in copper levels between the two groups. It is worth noting that there are differences in the values of copper levels between the TD and the control group, but not statistically different, which may be related to the small sample size of this group. Further point biserial correlation analysis showed a negative correlation between serum copper and TD. The relationship between copper and TD deserves further discussion.</p><p>Our study has several limitations: (1) all the children in this study are from a single center, and we selected serum trace element levels as the research object, which may not reflect the level of trace elements in the actual brain. (2) This study only reveal the relationship of trace element with tic disorder, it is still unclear whether supplementation of corresponding trace elements may help to control and improve symptoms of tics, further researches are needed. (3) TD always coexists with many common comorbidities. Our study did not further classify the subjects according to the comorbidities. The relationship between different comorbidities and trace elements still needs to be further explored. These limitations should be taken into consideration when the results interpreted.</p></sec><sec sec-type="conclusions" id="s5"><title>Conclusion</title><p>Our study shows that zinc deficiency was related to occurrence of TD and blood copper/iron levels in patients with TD were lower than those in the normal control group. Therefore, whether zinc supplementation can be used as an effective auxiliary means for controlling tics and whether children with TD need regular supplementation of trace element (Cu/Fe), deserve further exploration. We suggest a double-blind, placebo-controlled prospective study to reach a definite conclusion.</p></sec><sec sec-type="data-availability" id="s6"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.</p></sec><sec id="s7"><title>Ethics Statement</title><p>The studies involving human participants were reviewed and approved by institutional review committee of the Children's Hospital of Zhejiang University School of Medicine (2019-IRB-090). Written informed consent from the participants' legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.</p></sec><sec id="s8"><title>Author Contributions</title><p>RQ, YM, LY, SM, and FG participated in the design of the study, collected and analyzed the data, and drafted the manuscript. RQ, LY, SM, YZ, SL, JS, and ZY collected the data. LY, LJ, CY, and PJ was responsible for analysis, analyzed the data, and contributed in drafting the manuscript. RQ, YM, and SM contributed in drafting the manuscript. All authors read and approved the final manuscript.</p><sec><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></sec></body><back><ack><p>We would like to thank all the researchers for their work during the study. At the same time, we would like to thank all the children involved in the study, who helped us get the results of the study and help the further diagnosis and treatment of the disease.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This present study was supported by National Natural Science Foundation of China (Grant No. 81741076 and 81801490), Zhejiang Provincial Natural Science Foundation of China (Grant No. LQ17H090004), and Zhejiang medical and health science and technology project (Grant No. 2017200317).</p></fn></fn-group><ref-list><title>References</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>ZA</given-names></name><name><surname>Coffey</surname><given-names>BJ</given-names></name></person-group>. <article-title>Tics and Tourette syndrome</article-title>. <source>Psychiatr Clin North Am</source>. (<year>2014</year>) <volume>37</volume>:<fpage>269</fpage>&#x02013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.psc.2014.05.001</pub-id><?supplied-pmid 25150562?><pub-id pub-id-type="pmid">25150562</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freeman</surname><given-names>RD</given-names></name><name><surname>Fast</surname><given-names>DK</given-names></name><name><surname>Burd</surname><given-names>L</given-names></name><name><surname>Kerbeshian</surname><given-names>J</given-names></name><name><surname>Robertson</surname><given-names>MM</given-names></name><name><surname>Sandor</surname><given-names>P</given-names></name></person-group>. <article-title>An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries</article-title>. <source>Dev Med Child Neurol</source>. (<year>2000</year>) <volume>42</volume>:<fpage>436</fpage>&#x02013;<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1017/S0012162200000839</pub-id><?supplied-pmid 10972415?><pub-id pub-id-type="pmid">10972415</pub-id></mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group>. <article-title>Attention-deficit hyperactivity disorder</article-title>. <source>Lancet</source>. (<year>2005</year>) <volume>366</volume>:<fpage>237</fpage>&#x02013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)66915-2</pub-id><?supplied-pmid 16023516?><pub-id pub-id-type="pmid">16023516</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>TV</given-names></name><name><surname>State</surname><given-names>MW</given-names></name><name><surname>Pittenger</surname><given-names>C</given-names></name></person-group>. <article-title>Tourette disorder and other tic disorders</article-title>. <source>Handb Clin Neurol</source>. (<year>2018</year>) <volume>147</volume>:<fpage>343</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-63233-3.00023-3</pub-id><?supplied-pmid 29325623?><pub-id pub-id-type="pmid">29325623</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Mandell</surname><given-names>JD</given-names></name><name><surname>Kumar</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>N</given-names></name><name><surname>Morris</surname><given-names>MT</given-names></name><name><surname>Arbelaez</surname><given-names>J</given-names></name><etal/></person-group>. <article-title><italic>De novo</italic> sequence and copy number variants are strongly associated with tourette disorder and implicate cell polarity in pathogenesis</article-title>. <source>Cell Rep</source>. (<year>2018</year>) <volume>24</volume>:<fpage>3441</fpage>&#x02013;<lpage>54</lpage>.e12. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.12.024</pub-id><?supplied-pmid 30257206?><pub-id pub-id-type="pmid">30257206</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mataix-Cols</surname><given-names>D</given-names></name><name><surname>Isomura</surname><given-names>K</given-names></name><name><surname>Perez-Vigil</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>Z</given-names></name><name><surname>Ruck</surname><given-names>C</given-names></name><name><surname>Larsson</surname><given-names>KJ</given-names></name><etal/></person-group>. <article-title>Familial risks of tourette syndrome and chronic tic disorders. a population-based cohort study</article-title>. <source>JAMA Psychiatry</source>. (<year>2015</year>) <volume>72</volume>:<fpage>787</fpage>&#x02013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2015.0627</pub-id><?supplied-pmid 26083307?><pub-id pub-id-type="pmid">26083307</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hartmann</surname><given-names>A</given-names></name><name><surname>Worbe</surname><given-names>Y</given-names></name></person-group>. <article-title>Tourette syndrome: clinical spectrum, mechanisms and personalized treatments</article-title>. <source>Curr Opin Neurol</source>. (<year>2018</year>) <volume>31</volume>:<fpage>504</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1097/WCO.0000000000000575</pub-id><?supplied-pmid 29746399?><pub-id pub-id-type="pmid">29746399</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brainstorm</surname><given-names>C</given-names></name><name><surname>Anttila</surname><given-names>V</given-names></name><name><surname>Bulik-Sullivan</surname><given-names>B</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><name><surname>Walters</surname><given-names>RK</given-names></name><name><surname>Bras</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Analysis of shared heritability in common disorders of the brain</article-title>. <source>Science</source>. (<year>2018</year>) <volume>360</volume>:<fpage>eaap8757</fpage>
<pub-id pub-id-type="doi">10.1126/science.aap8757</pub-id><pub-id pub-id-type="pmid">29930110</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martino</surname><given-names>D</given-names></name><name><surname>Zis</surname><given-names>P</given-names></name><name><surname>Buttiglione</surname><given-names>M</given-names></name></person-group>. <article-title>The role of immune mechanisms in Tourette syndrome</article-title>. <source>Brain Res</source>. (<year>2015</year>) <volume>1617</volume>:<fpage>126</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2014.04.027</pub-id><?supplied-pmid 24845720?><pub-id pub-id-type="pmid">24845720</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>DL</given-names></name><name><surname>Mink</surname><given-names>JW</given-names></name><name><surname>Singer</surname><given-names>HS</given-names></name></person-group>. <article-title>A pediatric neurology perspective on pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection and pediatric acute-onset neuropsychiatric syndrome</article-title>. <source>J Pediatr</source>. (<year>2018</year>) <volume>199</volume>:<fpage>243</fpage>&#x02013;<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2018.04.035</pub-id><?supplied-pmid 29793872?><pub-id pub-id-type="pmid">29793872</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muth</surname><given-names>CC</given-names></name></person-group>. <article-title>Tics and Tourette syndrome</article-title>. <source>JAMA</source>. (<year>2017</year>) <volume>317</volume>:<fpage>1592</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2017.0547</pub-id><?supplied-pmid 28418483?><pub-id pub-id-type="pmid">28418483</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Hasenhuetl</surname><given-names>PS</given-names></name><name><surname>Schicker</surname><given-names>K</given-names></name><name><surname>Sitte</surname><given-names>HH</given-names></name><name><surname>Freissmuth</surname><given-names>M</given-names></name><name><surname>Sandtner</surname><given-names>W</given-names></name></person-group>. <article-title>Dual action of Zn2+ on the transport cycle of the dopamine transporter</article-title>. <source>J Biol Chem</source>. (<year>2015</year>) <volume>290</volume>:<fpage>31069</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.688275</pub-id><?supplied-pmid 26504078?><pub-id pub-id-type="pmid">26504078</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peran</surname><given-names>P</given-names></name><name><surname>Cherubini</surname><given-names>A</given-names></name><name><surname>Luccichenti</surname><given-names>G</given-names></name><name><surname>Hagberg</surname><given-names>G</given-names></name><name><surname>Demonet</surname><given-names>JF</given-names></name><name><surname>Rascol</surname><given-names>O</given-names></name><etal/></person-group>. <article-title>Volume and iron content in basal ganglia and thalamus</article-title>. <source>Hum Brain Mapp</source>. (<year>2009</year>) <volume>30</volume>:<fpage>2667</fpage>&#x02013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.20698</pub-id><?supplied-pmid 19172651?><pub-id pub-id-type="pmid">19172651</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>FH</given-names></name><name><surname>Ahlberg</surname><given-names>CD</given-names></name><name><surname>Chow</surname><given-names>CA</given-names></name><name><surname>Shah</surname><given-names>DR</given-names></name><name><surname>Koo</surname><given-names>BB</given-names></name></person-group>. <article-title>Iron, dopamine, genetics, and hormones in the pathophysiology of restless legs syndrome</article-title>. <source>J Neurol</source>. (<year>2017</year>) <volume>264</volume>:<fpage>1634</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-017-8431-1</pub-id><?supplied-pmid 28236139?><pub-id pub-id-type="pmid">28236139</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>R</given-names></name></person-group>. <article-title>Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)</article-title>. <source>Sleep Med</source>. (<year>2004</year>) <volume>5</volume>:<fpage>385</fpage>&#x02013;<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/j.sleep.2004.01.012</pub-id><?supplied-pmid 15222997?><pub-id pub-id-type="pmid">15222997</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lin</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name></person-group>. <article-title>Blood levels of trace elements in children with attention-deficit hyperactivity disorder: results from a case-control study</article-title>. <source>Biol Trace Elem Res</source>. (<year>2019</year>) <volume>187</volume>:<fpage>376</fpage>&#x02013;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1007/s12011-018-1408-9</pub-id><?supplied-pmid 29909491?><pub-id pub-id-type="pmid">29909491</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avrahami</surname><given-names>M</given-names></name><name><surname>Barzilay</surname><given-names>R</given-names></name><name><surname>HarGil</surname><given-names>M</given-names></name><name><surname>Weizman</surname><given-names>A</given-names></name><name><surname>Watemberg</surname><given-names>N</given-names></name></person-group>. <article-title>Serum ferritin levels are lower in children with tic disorders compared with children without tics: a cross-sectional study</article-title>. <source>J Child Adolesc Psychopharmacol</source>. (<year>2017</year>) <volume>27</volume>:<fpage>192</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2016.0069</pub-id><?supplied-pmid 27548271?><pub-id pub-id-type="pmid">27548271</pub-id></mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tagwerker Gloor</surname><given-names>F</given-names></name><name><surname>Walitza</surname><given-names>S</given-names></name></person-group>. <article-title>Tic disorders and tourette syndrome: current concepts of etiology and treatment in children and adolescents</article-title>. <source>Neuropediatrics</source>. (<year>2016</year>) <volume>47</volume>:<fpage>84</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1055/s-0035-1570492</pub-id><?supplied-pmid 26829367?><pub-id pub-id-type="pmid">26829367</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurlan</surname><given-names>R</given-names></name><name><surname>McDermott</surname><given-names>MP</given-names></name><name><surname>Deeley</surname><given-names>C</given-names></name><name><surname>Como</surname><given-names>PG</given-names></name><name><surname>Brower</surname><given-names>C</given-names></name><name><surname>Eapen</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Prevalence of tics in schoolchildren and association with placement in special education</article-title>. <source>Neurology</source>. (<year>2001</year>) <volume>57</volume>:<fpage>1383</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.57.8.1383</pub-id><?supplied-pmid 11673576?><pub-id pub-id-type="pmid">11673576</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddy</surname><given-names>CM</given-names></name><name><surname>Cavanna</surname><given-names>AE</given-names></name><name><surname>Gulisano</surname><given-names>M</given-names></name><name><surname>Agodi</surname><given-names>A</given-names></name><name><surname>Barchitta</surname><given-names>M</given-names></name><name><surname>Cali</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Clinical correlates of quality of life in Tourette syndrome</article-title>. <source>Mov Disord</source>. (<year>2011</year>) <volume>26</volume>:<fpage>735</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/mds.23434</pub-id><?supplied-pmid 21506153?><pub-id pub-id-type="pmid">21506153</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brander</surname><given-names>G</given-names></name><name><surname>Rydell</surname><given-names>M</given-names></name><name><surname>Kuja-Halkola</surname><given-names>R</given-names></name><name><surname>Fernandez de la Cruz</surname><given-names>L</given-names></name><name><surname>Lichtenstein</surname><given-names>P</given-names></name><name><surname>Serlachius</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Perinatal risk factors in Tourette's and chronic tic disorders: a total population sibling comparison study</article-title>. <source>Mol Psychiatry</source>. (<year>2018</year>) <volume>23</volume>:<fpage>1189</fpage>&#x02013;<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2017.31</pub-id><?supplied-pmid 28348386?><pub-id pub-id-type="pmid">28348386</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pringsheim</surname><given-names>T</given-names></name><name><surname>Holler-Managan</surname><given-names>Y</given-names></name><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Jankovic</surname><given-names>J</given-names></name><name><surname>Piacentini</surname><given-names>J</given-names></name><name><surname>Cavanna</surname><given-names>AE</given-names></name><etal/></person-group>. <article-title>Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders</article-title>. <source>Neurology</source>. (<year>2019</year>) <volume>92</volume>:<fpage>907</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000007467</pub-id><?supplied-pmid 31061209?><pub-id pub-id-type="pmid">31061209</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Ramirez</surname><given-names>D</given-names></name><name><surname>Jimenez-Shahed</surname><given-names>J</given-names></name><name><surname>Leckman</surname><given-names>JF</given-names></name><name><surname>Porta</surname><given-names>M</given-names></name><name><surname>Servello</surname><given-names>D</given-names></name><name><surname>Meng</surname><given-names>FG</given-names></name><etal/></person-group>. <article-title>Efficacy and safety of deep brain stimulation in Tourette syndrome: the international Tourette syndrome deep brain stimulation public database and registry</article-title>. <source>JAMA Neurol</source>. (<year>2018</year>) <volume>75</volume>:<fpage>353</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2017.4317</pub-id><?supplied-pmid 29340590?><pub-id pub-id-type="pmid">29340590</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kefalopoulou</surname><given-names>Z</given-names></name><name><surname>Zrinzo</surname><given-names>L</given-names></name><name><surname>Jahanshahi</surname><given-names>M</given-names></name><name><surname>Candelario</surname><given-names>J</given-names></name><name><surname>Milabo</surname><given-names>C</given-names></name><name><surname>Beigi</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Bilateral globus pallidus stimulation for severe Tourette's syndrome: a double-blind, randomised crossover trial</article-title>. <source>Lancet Neurol</source>. (<year>2015</year>) <volume>14</volume>:<fpage>595</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(15)00008-3</pub-id><?supplied-pmid 25882029?><pub-id pub-id-type="pmid">25882029</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welter</surname><given-names>ML</given-names></name><name><surname>Houeto</surname><given-names>JL</given-names></name><name><surname>Thobois</surname><given-names>S</given-names></name><name><surname>Bataille</surname><given-names>B</given-names></name><name><surname>Guenot</surname><given-names>M</given-names></name><name><surname>Worbe</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Anterior pallidal deep brain stimulation for Tourette's syndrome: a randomised, double-blind, controlled trial</article-title>. <source>Lancet Neurol</source>. (<year>2017</year>) <volume>16</volume>:<fpage>610</fpage>&#x02013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(17)30160-6</pub-id><?supplied-pmid 28645853?><pub-id pub-id-type="pmid">28645853</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ackermans</surname><given-names>L</given-names></name><name><surname>Duits</surname><given-names>A</given-names></name><name><surname>van der Linden</surname><given-names>C</given-names></name><name><surname>Tijssen</surname><given-names>M</given-names></name><name><surname>Schruers</surname><given-names>K</given-names></name><name><surname>Temel</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome</article-title>. <source>Brain</source>. (<year>2011</year>) <volume>134</volume>(<issue>Pt 3</issue>):<fpage>832</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awq380</pub-id><?supplied-pmid 21354977?><pub-id pub-id-type="pmid">21354977</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okun</surname><given-names>MS</given-names></name><name><surname>Foote</surname><given-names>KD</given-names></name><name><surname>Wu</surname><given-names>SS</given-names></name><name><surname>Ward</surname><given-names>HE</given-names></name><name><surname>Bowers</surname><given-names>D</given-names></name><name><surname>Rodriguez</surname><given-names>RL</given-names></name><etal/></person-group>. <article-title>A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms</article-title>. <source>JAMA Neurol</source>. (<year>2013</year>) <volume>70</volume>:<fpage>85</fpage>&#x02013;<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1001/jamaneurol.2013.580</pub-id><?supplied-pmid 23044532?><pub-id pub-id-type="pmid">23044532</pub-id></mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciunas</surname><given-names>RJ</given-names></name><name><surname>Maddux</surname><given-names>BN</given-names></name><name><surname>Riley</surname><given-names>DE</given-names></name><name><surname>Whitney</surname><given-names>CM</given-names></name><name><surname>Schoenberg</surname><given-names>MR</given-names></name><name><surname>Ogrocki</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>Prospective randomized double-blind trial of bilateral thalamic deep brain stimulation in adults with Tourette syndrome</article-title>. <source>J Neurosurg</source>. (<year>2007</year>) <volume>107</volume>:<fpage>1004</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.3171/jns.2007.107.5.1004</pub-id><?supplied-pmid 17977274?><pub-id pub-id-type="pmid">17977274</pub-id></mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Battle</surname><given-names>DE</given-names></name></person-group>. <article-title>Diagnostic and statistical manual of mental disorders (DSM)</article-title>. <source>Codas</source>. (<year>2013</year>) <volume>25</volume>:<fpage>191</fpage>&#x02013;<lpage>2</lpage>. <pub-id pub-id-type="doi">10.1590/s2317-17822013000200017</pub-id><?supplied-pmid 24413388?><pub-id pub-id-type="pmid">24413388</pub-id></mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>KW</given-names></name><name><surname>Hauser</surname><given-names>J</given-names></name><name><surname>Lange</surname><given-names>KM</given-names></name><name><surname>Makulska-Gertruda</surname><given-names>E</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Reissmann</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>The role of nutritional supplements in the treatment of ADHD: what the evidence says</article-title>. <source>Curr Psychiatry Rep</source>. (<year>2017</year>) <volume>19</volume>:<fpage>8</fpage>. <pub-id pub-id-type="doi">10.1007/s11920-017-0762-1</pub-id><?supplied-pmid 28168597?><pub-id pub-id-type="pmid">28168597</pub-id></mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Burkman</surname><given-names>E</given-names></name></person-group>. <article-title>Relationship of serum ferritin level and tic severity in children with Tourette syndrome</article-title>. <source>Childs Nerv Syst</source>. (<year>2017</year>) <volume>33</volume>:<fpage>1373</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s00381-017-3424-z</pub-id><?supplied-pmid 28470381?><pub-id pub-id-type="pmid">28470381</pub-id></mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirschtritt</surname><given-names>ME</given-names></name><name><surname>Lee</surname><given-names>PC</given-names></name><name><surname>Pauls</surname><given-names>DL</given-names></name><name><surname>Dion</surname><given-names>Y</given-names></name><name><surname>Grados</surname><given-names>MA</given-names></name><name><surname>Illmann</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome</article-title>. <source>JAMA Psychiatry</source>. (<year>2015</year>) <volume>72</volume>:<fpage>325</fpage>&#x02013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1001/jamapsychiatry.2014.2650</pub-id><?supplied-pmid 25671412?><pub-id pub-id-type="pmid">25671412</pub-id></mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D</given-names></name><name><surname>Rajan</surname><given-names>PV</given-names></name><name><surname>Das</surname><given-names>D</given-names></name><name><surname>Datta</surname><given-names>P</given-names></name><name><surname>Rothner</surname><given-names>AD</given-names></name><name><surname>Erenberg</surname><given-names>G</given-names></name></person-group>. <article-title>Sleep disorders in children with Tourette syndrome</article-title>. <source>Pediatr Neurol</source>. (<year>2014</year>) <volume>51</volume>:<fpage>31</fpage>&#x02013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.03.017</pub-id><?supplied-pmid 24938137?><pub-id pub-id-type="pmid">24938137</pub-id></mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>GX</given-names></name><name><surname>Wang</surname><given-names>BH</given-names></name><name><surname>Zhang</surname><given-names>YF</given-names></name></person-group>. <article-title>Relationship between serum zinc levels and attention deficit hyperactivity disorder in children</article-title>. <source>Zhongguo Dang Dai Er Ke Za Zhi</source>. (<year>2015</year>) <volume>17</volume>:<fpage>980</fpage>&#x02013;<lpage>3</lpage>. <pub-id pub-id-type="doi">10.7499/j.issn.1008-8830.2015.09.019</pub-id><?supplied-pmid 26412183?><pub-id pub-id-type="pmid">26412183</pub-id></mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golub</surname><given-names>MS</given-names></name><name><surname>Takeuchi</surname><given-names>PT</given-names></name><name><surname>Keen</surname><given-names>CL</given-names></name><name><surname>Hendrickx</surname><given-names>AG</given-names></name><name><surname>Gershwin</surname><given-names>ME</given-names></name></person-group>. <article-title>Activity and attention in zinc-deprived adolescent monkeys</article-title>. <source>Am J Clin Nutr</source>. (<year>1996</year>) <volume>64</volume>:<fpage>908</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/64.6.908</pub-id><?supplied-pmid 8942416?><pub-id pub-id-type="pmid">8942416</pub-id></mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aggett</surname><given-names>PJ</given-names></name><name><surname>Harries</surname><given-names>JT</given-names></name></person-group>. <article-title>Current status of zinc in health and disease states</article-title>. <source>Arch Dis Child</source>. (<year>1979</year>) <volume>54</volume>:<fpage>909</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1136/adc.54.12.909</pub-id><?supplied-pmid 119488?><pub-id pub-id-type="pmid">119488</pub-id></mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hurley</surname><given-names>LS</given-names></name></person-group>. <article-title>The roles of trace elements in foetal and neonatal development</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. (<year>1981</year>) <volume>294</volume>:<fpage>145</fpage>&#x02013;<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1098/rstb.1981.0095</pub-id><?supplied-pmid 6118892?><pub-id pub-id-type="pmid">6118892</pub-id></mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandyk</surname><given-names>R</given-names></name></person-group>. <article-title>Zinc deficiency in attention-deficit hyperactivity disorder</article-title>. <source>Int J Neurosci</source>. (<year>1990</year>) <volume>52</volume>:<fpage>239</fpage>&#x02013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.3109/00207459009000526</pub-id><?supplied-pmid 2269611?><pub-id pub-id-type="pmid">2269611</pub-id></mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>MD</given-names></name><name><surname>Lin</surname><given-names>PY</given-names></name><name><surname>Sheu</surname><given-names>WH</given-names></name></person-group>. <article-title>Zinc coadministration attenuates melatonin's effect on nitric oxide production in mice</article-title>. <source>Biol Trace Elem Res</source>. (<year>1999</year>) <volume>69</volume>:<fpage>261</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/BF02783878</pub-id><?supplied-pmid 10468163?><pub-id pub-id-type="pmid">10468163</pub-id></mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lepping</surname><given-names>P</given-names></name><name><surname>Huber</surname><given-names>M</given-names></name></person-group>. <article-title>Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment</article-title>. <source>CNS Drugs</source>. (<year>2010</year>) <volume>24</volume>:<fpage>721</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2165/11537610-000000000-00000</pub-id><?supplied-pmid 20806985?><pub-id pub-id-type="pmid">20806985</pub-id></mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghanizadeh</surname><given-names>A</given-names></name><name><surname>Berk</surname><given-names>M</given-names></name></person-group>. <article-title>Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials</article-title>. <source>Eur J Clin Nutr</source>. (<year>2013</year>) <volume>67</volume>:<fpage>122</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1038/ejcn.2012.177</pub-id><?supplied-pmid 23169472?><pub-id pub-id-type="pmid">23169472</pub-id></mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Qu</surname><given-names>Y</given-names></name><name><surname>Mu</surname><given-names>D</given-names></name></person-group>. <article-title>Iron status in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis</article-title>. <source>PLoS ONE</source>. (<year>2017</year>) <volume>12</volume>:<fpage>e0169145</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0169145</pub-id><?supplied-pmid 28046016?><pub-id pub-id-type="pmid">28046016</pub-id></mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sachdev</surname><given-names>P</given-names></name></person-group>. <article-title>The neuropsychiatry of brain iron</article-title>. <source>J Neuropsychiatry Clin Neurosci</source>. (<year>1993</year>) <volume>5</volume>:<fpage>18</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1176/jnp.5.1.18</pub-id><?supplied-pmid 8094018?><pub-id pub-id-type="pmid">8094018</pub-id></mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erikson</surname><given-names>KM</given-names></name><name><surname>Jones</surname><given-names>BC</given-names></name><name><surname>Beard</surname><given-names>JL</given-names></name></person-group>. <article-title>Iron deficiency alters dopamine transporter functioning in rat striatum</article-title>. <source>J Nutr</source>. (<year>2000</year>) <volume>130</volume>:<fpage>2831</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1093/jn/130.11.2831</pub-id><?supplied-pmid 11053528?><pub-id pub-id-type="pmid">11053528</pub-id></mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lozoff</surname><given-names>B</given-names></name></person-group>. <article-title>Early iron deficiency has brain and behavior effects consistent with dopaminergic dysfunction</article-title>. <source>J Nutr</source>. (<year>2011</year>) <volume>141</volume>:<fpage>740S</fpage>&#x02212;<lpage>6S</lpage>. <pub-id pub-id-type="doi">10.3945/jn.110.131169</pub-id><?supplied-pmid 21346104?><pub-id pub-id-type="pmid">21346104</pub-id></mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Youdim</surname><given-names>MB</given-names></name><name><surname>Ben-Shachar</surname><given-names>D</given-names></name><name><surname>Yehuda</surname><given-names>S</given-names></name></person-group>. <article-title>Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior</article-title>. <source>Am J Clin Nutr</source>. (<year>1989</year>) <volume>50</volume>(<issue>Suppl. 3</issue>):<fpage>607</fpage>&#x02013;<lpage>15</lpage>; discussion: 15&#x02013;7. <pub-id pub-id-type="doi">10.1093/ajcn/50.3.607</pub-id><?supplied-pmid 2773840?><pub-id pub-id-type="pmid">2773840</pub-id></mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>EF</given-names></name><name><surname>Posner</surname><given-names>J</given-names></name></person-group>. <article-title>Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms</article-title>. <source>Lancet Psychiatry</source>. (<year>2016</year>) <volume>3</volume>:<fpage>555</fpage>&#x02013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/S2215-0366(16)00096-1</pub-id><?supplied-pmid 27183902?><pub-id pub-id-type="pmid">27183902</pub-id></mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>JM</given-names></name></person-group>. <article-title>Iron concentration reduced in ventral pallidum, globus pallidus, and substantia nigra by GABA-transaminase inhibitor, gamma-vinyl GABA</article-title>. <source>Brain Res</source>. (<year>1985</year>) <volume>342</volume>:<fpage>18</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(85)91348-4</pub-id><?supplied-pmid 4041811?><pub-id pub-id-type="pmid">4041811</pub-id></mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortese</surname><given-names>S</given-names></name><name><surname>Azoulay</surname><given-names>R</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Chalard</surname><given-names>F</given-names></name><name><surname>Lecendreux</surname><given-names>M</given-names></name><name><surname>Chechin</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Brain iron levels in attention-deficit/hyperactivity disorder: a pilot MRI study</article-title>. <source>World J Biol Psychiatry</source>. (<year>2012</year>) <volume>13</volume>:<fpage>223</fpage>&#x02013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.3109/15622975.2011.570376</pub-id><?supplied-pmid 21585274?><pub-id pub-id-type="pmid">21585274</pub-id></mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>WR</given-names></name><name><surname>Jiang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>JX</given-names></name></person-group>. <article-title>Copper (Cu2+) induces degeneration of dopaminergic neurons in the nigrostriatal system of rats</article-title>. <source>Neurosci Bull</source>. (<year>2008</year>) <volume>24</volume>:<fpage>73</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1007/s12264-008-0073-y</pub-id><?supplied-pmid 18369385?><pub-id pub-id-type="pmid">18369385</pub-id></mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Llanos</surname><given-names>RM</given-names></name><name><surname>Mercer</surname><given-names>JF</given-names></name></person-group>. <article-title>The molecular basis of copper homeostasis copper-related disorders</article-title>. <source>DNA Cell Biol</source>. (<year>2002</year>) <volume>21</volume>:<fpage>259</fpage>&#x02013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1089/104454902753759681</pub-id><?supplied-pmid 12042066?><pub-id pub-id-type="pmid">12042066</pub-id></mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viktorinova</surname><given-names>A</given-names></name><name><surname>Ursinyova</surname><given-names>M</given-names></name><name><surname>Trebaticka</surname><given-names>J</given-names></name><name><surname>Uhnakova</surname><given-names>I</given-names></name><name><surname>Durackova</surname><given-names>Z</given-names></name><name><surname>Masanova</surname><given-names>V</given-names></name></person-group>. <article-title>Changed plasma levels of zinc and copper to zinc ratio and their possible associations with parent- and teacher-rated symptoms in children with attention-deficit hyperactivity disorder</article-title>. <source>Biol Trace Elem Res</source>. (<year>2016</year>) <volume>169</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1007/s12011-015-0395-3</pub-id><?supplied-pmid 26063047?><pub-id pub-id-type="pmid">26063047</pub-id></mixed-citation></ref></ref-list></back></article>